Left Cardiac Catheterization
1 clinical trials · Condition
◉ Watch Left Cardiac Catheterization
| Record | Firm | Date |
|---|---|---|
| Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention (NCT04806633) | G.Gennimatas General Hospital | 2021-04-01 |
Track Left Cardiac Catheterization automatically
Every clearance here is in the API, with alerts when new ones post.